Global Targeted Drug ALK Inhibitors for NSCLC Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Targeted Drug ALK Inhibitors for NSCLC Industry Forecast” looks at past sales and reviews total world Targeted Drug ALK Inhibitors for NSCLC sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted Drug ALK Inhibitors for NSCLC sales for 2023 through 2029. With Targeted Drug ALK Inhibitors for NSCLC sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drug ALK Inhibitors for NSCLC industry.
This Insight Report provides a comprehensive analysis of the global Targeted Drug ALK Inhibitors for NSCLC landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Drug ALK Inhibitors for NSCLC portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drug ALK Inhibitors for NSCLC market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drug ALK Inhibitors for NSCLC and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drug ALK Inhibitors for NSCLC.
The global Targeted Drug ALK Inhibitors for NSCLC market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Targeted Drug ALK Inhibitors for NSCLC is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Targeted Drug ALK Inhibitors for NSCLC is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Targeted Drug ALK Inhibitors for NSCLC is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Targeted Drug ALK Inhibitors for NSCLC players cover Pfizer, Novartis, Chugai Pharmaceutical (Hoffmann-La Roche group), ARIAD Pharmaceuticals (Takeda), Genvio Pharma Limited, Beacon Pharma Limited, Drug International Limted and Incepta Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drug ALK Inhibitors for NSCLC market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Targeted Drug ALK Inhibitors for NSCLC Industry Forecast” looks at past sales and reviews total world Targeted Drug ALK Inhibitors for NSCLC sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted Drug ALK Inhibitors for NSCLC sales for 2023 through 2029. With Targeted Drug ALK Inhibitors for NSCLC sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Drug ALK Inhibitors for NSCLC industry.
This Insight Report provides a comprehensive analysis of the global Targeted Drug ALK Inhibitors for NSCLC landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted Drug ALK Inhibitors for NSCLC portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Drug ALK Inhibitors for NSCLC market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Drug ALK Inhibitors for NSCLC and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Drug ALK Inhibitors for NSCLC.
The global Targeted Drug ALK Inhibitors for NSCLC market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Targeted Drug ALK Inhibitors for NSCLC is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Targeted Drug ALK Inhibitors for NSCLC is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Targeted Drug ALK Inhibitors for NSCLC is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Targeted Drug ALK Inhibitors for NSCLC players cover Pfizer, Novartis, Chugai Pharmaceutical (Hoffmann-La Roche group), ARIAD Pharmaceuticals (Takeda), Genvio Pharma Limited, Beacon Pharma Limited, Drug International Limted and Incepta Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Drug ALK Inhibitors for NSCLC market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Crizotinib
- Ceritinib
- Alectinib
- Brigatinib
- Lorlatinib
- Other
- Squamous Cell Carcinoma of NSCLC
- Adenocarcinoma of NSCLC
- Large Cell Carcinoma of NSCLC
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Novartis
- Chugai Pharmaceutical (Hoffmann-La Roche group)
- ARIAD Pharmaceuticals (Takeda)
- Genvio Pharma Limited
- Beacon Pharma Limited
- Drug International Limted
- Incepta Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Drug ALK Inhibitors for NSCLC Market Size 2018-2029
2.1.2 Targeted Drug ALK Inhibitors for NSCLC Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Targeted Drug ALK Inhibitors for NSCLC Segment by Type
2.2.1 Crizotinib
2.2.2 Ceritinib
2.2.3 Alectinib
2.2.4 Brigatinib
2.2.5 Lorlatinib
2.2.6 Other
2.3 Targeted Drug ALK Inhibitors for NSCLC Market Size by Type
2.3.1 Targeted Drug ALK Inhibitors for NSCLC Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
2.4 Targeted Drug ALK Inhibitors for NSCLC Segment by Application
2.4.1 Squamous Cell Carcinoma of NSCLC
2.4.2 Adenocarcinoma of NSCLC
2.4.3 Large Cell Carcinoma of NSCLC
2.5 Targeted Drug ALK Inhibitors for NSCLC Market Size by Application
2.5.1 Targeted Drug ALK Inhibitors for NSCLC Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
3 TARGETED DRUG ALK INHIBITORS FOR NSCLC MARKET SIZE BY PLAYER
3.1 Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Players
3.1.1 Global Targeted Drug ALK Inhibitors for NSCLC Revenue by Players (2018-2023)
3.1.2 Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Players (2018-2023)
3.2 Global Targeted Drug ALK Inhibitors for NSCLC Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED DRUG ALK INHIBITORS FOR NSCLC BY REGIONS
4.1 Targeted Drug ALK Inhibitors for NSCLC Market Size by Regions (2018-2023)
4.2 Americas Targeted Drug ALK Inhibitors for NSCLC Market Size Growth (2018-2023)
4.3 APAC Targeted Drug ALK Inhibitors for NSCLC Market Size Growth (2018-2023)
4.4 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size Growth (2018-2023)
4.5 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2018-2023)
5.2 Americas Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023)
5.3 Americas Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Drug ALK Inhibitors for NSCLC Market Size by Region (2018-2023)
6.2 APAC Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023)
6.3 APAC Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Drug ALK Inhibitors for NSCLC by Country (2018-2023)
7.2 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023)
7.3 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC by Region (2018-2023)
8.2 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023)
8.3 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED DRUG ALK INHIBITORS FOR NSCLC MARKET FORECAST
10.1 Global Targeted Drug ALK Inhibitors for NSCLC Forecast by Regions (2024-2029)
10.1.1 Global Targeted Drug ALK Inhibitors for NSCLC Forecast by Regions (2024-2029)
10.1.2 Americas Targeted Drug ALK Inhibitors for NSCLC Forecast
10.1.3 APAC Targeted Drug ALK Inhibitors for NSCLC Forecast
10.1.4 Europe Targeted Drug ALK Inhibitors for NSCLC Forecast
10.1.5 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Forecast
10.2 Americas Targeted Drug ALK Inhibitors for NSCLC Forecast by Country (2024-2029)
10.2.1 United States Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.2.2 Canada Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.2.3 Mexico Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.2.4 Brazil Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.3 APAC Targeted Drug ALK Inhibitors for NSCLC Forecast by Region (2024-2029)
10.3.1 China Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.3.2 Japan Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.3.3 Korea Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.3.4 Southeast Asia Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.3.5 India Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.3.6 Australia Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.4 Europe Targeted Drug ALK Inhibitors for NSCLC Forecast by Country (2024-2029)
10.4.1 Germany Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.4.2 France Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.4.3 UK Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.4.4 Italy Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.4.5 Russia Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.5 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Forecast by Region (2024-2029)
10.5.1 Egypt Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.5.2 South Africa Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.5.3 Israel Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.5.4 Turkey Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.5.5 GCC Countries Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.6 Global Targeted Drug ALK Inhibitors for NSCLC Forecast by Type (2024-2029)
10.7 Global Targeted Drug ALK Inhibitors for NSCLC Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.1.3 Pfizer Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.2.3 Novartis Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Chugai Pharmaceutical (Hoffmann-La Roche group)
11.3.1 Chugai Pharmaceutical (Hoffmann-La Roche group) Company Information
11.3.2 Chugai Pharmaceutical (Hoffmann-La Roche group) Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.3.3 Chugai Pharmaceutical (Hoffmann-La Roche group) Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Chugai Pharmaceutical (Hoffmann-La Roche group) Main Business Overview
11.3.5 Chugai Pharmaceutical (Hoffmann-La Roche group) Latest Developments
11.4 ARIAD Pharmaceuticals (Takeda)
11.4.1 ARIAD Pharmaceuticals (Takeda) Company Information
11.4.2 ARIAD Pharmaceuticals (Takeda) Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.4.3 ARIAD Pharmaceuticals (Takeda) Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 ARIAD Pharmaceuticals (Takeda) Main Business Overview
11.4.5 ARIAD Pharmaceuticals (Takeda) Latest Developments
11.5 Genvio Pharma Limited
11.5.1 Genvio Pharma Limited Company Information
11.5.2 Genvio Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.5.3 Genvio Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Genvio Pharma Limited Main Business Overview
11.5.5 Genvio Pharma Limited Latest Developments
11.6 Beacon Pharma Limited
11.6.1 Beacon Pharma Limited Company Information
11.6.2 Beacon Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.6.3 Beacon Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Beacon Pharma Limited Main Business Overview
11.6.5 Beacon Pharma Limited Latest Developments
11.7 Drug International Limted
11.7.1 Drug International Limted Company Information
11.7.2 Drug International Limted Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.7.3 Drug International Limted Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Drug International Limted Main Business Overview
11.7.5 Drug International Limted Latest Developments
11.8 Incepta Pharmaceuticals
11.8.1 Incepta Pharmaceuticals Company Information
11.8.2 Incepta Pharmaceuticals Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.8.3 Incepta Pharmaceuticals Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Incepta Pharmaceuticals Main Business Overview
11.8.5 Incepta Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Drug ALK Inhibitors for NSCLC Market Size 2018-2029
2.1.2 Targeted Drug ALK Inhibitors for NSCLC Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Targeted Drug ALK Inhibitors for NSCLC Segment by Type
2.2.1 Crizotinib
2.2.2 Ceritinib
2.2.3 Alectinib
2.2.4 Brigatinib
2.2.5 Lorlatinib
2.2.6 Other
2.3 Targeted Drug ALK Inhibitors for NSCLC Market Size by Type
2.3.1 Targeted Drug ALK Inhibitors for NSCLC Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
2.4 Targeted Drug ALK Inhibitors for NSCLC Segment by Application
2.4.1 Squamous Cell Carcinoma of NSCLC
2.4.2 Adenocarcinoma of NSCLC
2.4.3 Large Cell Carcinoma of NSCLC
2.5 Targeted Drug ALK Inhibitors for NSCLC Market Size by Application
2.5.1 Targeted Drug ALK Inhibitors for NSCLC Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
3 TARGETED DRUG ALK INHIBITORS FOR NSCLC MARKET SIZE BY PLAYER
3.1 Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Players
3.1.1 Global Targeted Drug ALK Inhibitors for NSCLC Revenue by Players (2018-2023)
3.1.2 Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Players (2018-2023)
3.2 Global Targeted Drug ALK Inhibitors for NSCLC Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED DRUG ALK INHIBITORS FOR NSCLC BY REGIONS
4.1 Targeted Drug ALK Inhibitors for NSCLC Market Size by Regions (2018-2023)
4.2 Americas Targeted Drug ALK Inhibitors for NSCLC Market Size Growth (2018-2023)
4.3 APAC Targeted Drug ALK Inhibitors for NSCLC Market Size Growth (2018-2023)
4.4 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size Growth (2018-2023)
4.5 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2018-2023)
5.2 Americas Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023)
5.3 Americas Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Drug ALK Inhibitors for NSCLC Market Size by Region (2018-2023)
6.2 APAC Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023)
6.3 APAC Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Drug ALK Inhibitors for NSCLC by Country (2018-2023)
7.2 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023)
7.3 Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC by Region (2018-2023)
8.2 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023)
8.3 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED DRUG ALK INHIBITORS FOR NSCLC MARKET FORECAST
10.1 Global Targeted Drug ALK Inhibitors for NSCLC Forecast by Regions (2024-2029)
10.1.1 Global Targeted Drug ALK Inhibitors for NSCLC Forecast by Regions (2024-2029)
10.1.2 Americas Targeted Drug ALK Inhibitors for NSCLC Forecast
10.1.3 APAC Targeted Drug ALK Inhibitors for NSCLC Forecast
10.1.4 Europe Targeted Drug ALK Inhibitors for NSCLC Forecast
10.1.5 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Forecast
10.2 Americas Targeted Drug ALK Inhibitors for NSCLC Forecast by Country (2024-2029)
10.2.1 United States Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.2.2 Canada Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.2.3 Mexico Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.2.4 Brazil Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.3 APAC Targeted Drug ALK Inhibitors for NSCLC Forecast by Region (2024-2029)
10.3.1 China Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.3.2 Japan Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.3.3 Korea Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.3.4 Southeast Asia Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.3.5 India Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.3.6 Australia Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.4 Europe Targeted Drug ALK Inhibitors for NSCLC Forecast by Country (2024-2029)
10.4.1 Germany Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.4.2 France Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.4.3 UK Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.4.4 Italy Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.4.5 Russia Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.5 Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Forecast by Region (2024-2029)
10.5.1 Egypt Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.5.2 South Africa Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.5.3 Israel Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.5.4 Turkey Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.5.5 GCC Countries Targeted Drug ALK Inhibitors for NSCLC Market Forecast
10.6 Global Targeted Drug ALK Inhibitors for NSCLC Forecast by Type (2024-2029)
10.7 Global Targeted Drug ALK Inhibitors for NSCLC Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.1.3 Pfizer Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.2.3 Novartis Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Chugai Pharmaceutical (Hoffmann-La Roche group)
11.3.1 Chugai Pharmaceutical (Hoffmann-La Roche group) Company Information
11.3.2 Chugai Pharmaceutical (Hoffmann-La Roche group) Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.3.3 Chugai Pharmaceutical (Hoffmann-La Roche group) Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Chugai Pharmaceutical (Hoffmann-La Roche group) Main Business Overview
11.3.5 Chugai Pharmaceutical (Hoffmann-La Roche group) Latest Developments
11.4 ARIAD Pharmaceuticals (Takeda)
11.4.1 ARIAD Pharmaceuticals (Takeda) Company Information
11.4.2 ARIAD Pharmaceuticals (Takeda) Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.4.3 ARIAD Pharmaceuticals (Takeda) Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 ARIAD Pharmaceuticals (Takeda) Main Business Overview
11.4.5 ARIAD Pharmaceuticals (Takeda) Latest Developments
11.5 Genvio Pharma Limited
11.5.1 Genvio Pharma Limited Company Information
11.5.2 Genvio Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.5.3 Genvio Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Genvio Pharma Limited Main Business Overview
11.5.5 Genvio Pharma Limited Latest Developments
11.6 Beacon Pharma Limited
11.6.1 Beacon Pharma Limited Company Information
11.6.2 Beacon Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.6.3 Beacon Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Beacon Pharma Limited Main Business Overview
11.6.5 Beacon Pharma Limited Latest Developments
11.7 Drug International Limted
11.7.1 Drug International Limted Company Information
11.7.2 Drug International Limted Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.7.3 Drug International Limted Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Drug International Limted Main Business Overview
11.7.5 Drug International Limted Latest Developments
11.8 Incepta Pharmaceuticals
11.8.1 Incepta Pharmaceuticals Company Information
11.8.2 Incepta Pharmaceuticals Targeted Drug ALK Inhibitors for NSCLC Product Offered
11.8.3 Incepta Pharmaceuticals Targeted Drug ALK Inhibitors for NSCLC Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Incepta Pharmaceuticals Main Business Overview
11.8.5 Incepta Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Targeted Drug ALK Inhibitors for NSCLC Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Crizotinib
Table 3. Major Players of Ceritinib
Table 4. Major Players of Alectinib
Table 5. Major Players of Brigatinib
Table 6. Major Players of Lorlatinib
Table 7. Major Players of Other
Table 8. Targeted Drug ALK Inhibitors for NSCLC Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 10. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
Table 11. Targeted Drug ALK Inhibitors for NSCLC Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 12. Global Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 13. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
Table 14. Global Targeted Drug ALK Inhibitors for NSCLC Revenue by Players (2018-2023) & ($ Millions)
Table 15. Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Player (2018-2023)
Table 16. Targeted Drug ALK Inhibitors for NSCLC Key Players Head office and Products Offered
Table 17. Targeted Drug ALK Inhibitors for NSCLC Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Targeted Drug ALK Inhibitors for NSCLC Market Size by Regions 2018-2023 & ($ Millions)
Table 21. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Regions (2018-2023)
Table 22. Global Targeted Drug ALK Inhibitors for NSCLC Revenue by Country/Region (2018-2023) & ($ millions)
Table 23. Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Country/Region (2018-2023)
Table 24. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2018-2023) & ($ Millions)
Table 25. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Country (2018-2023)
Table 26. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 27. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
Table 28. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 29. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
Table 30. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size by Region (2018-2023) & ($ Millions)
Table 31. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Region (2018-2023)
Table 32. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 33. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
Table 34. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 35. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
Table 36. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2018-2023) & ($ Millions)
Table 37. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Country (2018-2023)
Table 38. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 39. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
Table 40. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 41. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
Table 42. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Region (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Region (2018-2023)
Table 44. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
Table 46. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
Table 48. Key Market Drivers & Growth Opportunities of Targeted Drug ALK Inhibitors for NSCLC
Table 49. Key Market Challenges & Risks of Targeted Drug ALK Inhibitors for NSCLC
Table 50. Key Industry Trends of Targeted Drug ALK Inhibitors for NSCLC
Table 51. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 52. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share Forecast by Regions (2024-2029)
Table 53. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 54. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 55. Pfizer Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 56. Pfizer Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 57. Pfizer Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 58. Pfizer Main Business
Table 59. Pfizer Latest Developments
Table 60. Novartis Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 61. Novartis Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 62. Novartis Main Business
Table 63. Novartis Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 64. Novartis Latest Developments
Table 65. Chugai Pharmaceutical (Hoffmann-La Roche group) Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 66. Chugai Pharmaceutical (Hoffmann-La Roche group) Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 67. Chugai Pharmaceutical (Hoffmann-La Roche group) Main Business
Table 68. Chugai Pharmaceutical (Hoffmann-La Roche group) Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 69. Chugai Pharmaceutical (Hoffmann-La Roche group) Latest Developments
Table 70. ARIAD Pharmaceuticals (Takeda) Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 71. ARIAD Pharmaceuticals (Takeda) Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 72. ARIAD Pharmaceuticals (Takeda) Main Business
Table 73. ARIAD Pharmaceuticals (Takeda) Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 74. ARIAD Pharmaceuticals (Takeda) Latest Developments
Table 75. Genvio Pharma Limited Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 76. Genvio Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 77. Genvio Pharma Limited Main Business
Table 78. Genvio Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 79. Genvio Pharma Limited Latest Developments
Table 80. Beacon Pharma Limited Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 81. Beacon Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 82. Beacon Pharma Limited Main Business
Table 83. Beacon Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 84. Beacon Pharma Limited Latest Developments
Table 85. Drug International Limted Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 86. Drug International Limted Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 87. Drug International Limted Main Business
Table 88. Drug International Limted Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 89. Drug International Limted Latest Developments
Table 90. Incepta Pharmaceuticals Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 91. Incepta Pharmaceuticals Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 92. Incepta Pharmaceuticals Main Business
Table 93. Incepta Pharmaceuticals Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 94. Incepta Pharmaceuticals Latest Developments
Table 1. Targeted Drug ALK Inhibitors for NSCLC Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Crizotinib
Table 3. Major Players of Ceritinib
Table 4. Major Players of Alectinib
Table 5. Major Players of Brigatinib
Table 6. Major Players of Lorlatinib
Table 7. Major Players of Other
Table 8. Targeted Drug ALK Inhibitors for NSCLC Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 10. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
Table 11. Targeted Drug ALK Inhibitors for NSCLC Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 12. Global Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 13. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
Table 14. Global Targeted Drug ALK Inhibitors for NSCLC Revenue by Players (2018-2023) & ($ Millions)
Table 15. Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Player (2018-2023)
Table 16. Targeted Drug ALK Inhibitors for NSCLC Key Players Head office and Products Offered
Table 17. Targeted Drug ALK Inhibitors for NSCLC Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Targeted Drug ALK Inhibitors for NSCLC Market Size by Regions 2018-2023 & ($ Millions)
Table 21. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Regions (2018-2023)
Table 22. Global Targeted Drug ALK Inhibitors for NSCLC Revenue by Country/Region (2018-2023) & ($ millions)
Table 23. Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Country/Region (2018-2023)
Table 24. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2018-2023) & ($ Millions)
Table 25. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Country (2018-2023)
Table 26. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 27. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
Table 28. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 29. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
Table 30. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size by Region (2018-2023) & ($ Millions)
Table 31. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Region (2018-2023)
Table 32. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 33. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
Table 34. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 35. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
Table 36. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Country (2018-2023) & ($ Millions)
Table 37. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Country (2018-2023)
Table 38. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 39. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
Table 40. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 41. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
Table 42. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Region (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Region (2018-2023)
Table 44. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Type (2018-2023) & ($ Millions)
Table 45. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
Table 46. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size by Application (2018-2023) & ($ Millions)
Table 47. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
Table 48. Key Market Drivers & Growth Opportunities of Targeted Drug ALK Inhibitors for NSCLC
Table 49. Key Market Challenges & Risks of Targeted Drug ALK Inhibitors for NSCLC
Table 50. Key Industry Trends of Targeted Drug ALK Inhibitors for NSCLC
Table 51. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 52. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share Forecast by Regions (2024-2029)
Table 53. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 54. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 55. Pfizer Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 56. Pfizer Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 57. Pfizer Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 58. Pfizer Main Business
Table 59. Pfizer Latest Developments
Table 60. Novartis Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 61. Novartis Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 62. Novartis Main Business
Table 63. Novartis Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 64. Novartis Latest Developments
Table 65. Chugai Pharmaceutical (Hoffmann-La Roche group) Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 66. Chugai Pharmaceutical (Hoffmann-La Roche group) Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 67. Chugai Pharmaceutical (Hoffmann-La Roche group) Main Business
Table 68. Chugai Pharmaceutical (Hoffmann-La Roche group) Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 69. Chugai Pharmaceutical (Hoffmann-La Roche group) Latest Developments
Table 70. ARIAD Pharmaceuticals (Takeda) Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 71. ARIAD Pharmaceuticals (Takeda) Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 72. ARIAD Pharmaceuticals (Takeda) Main Business
Table 73. ARIAD Pharmaceuticals (Takeda) Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 74. ARIAD Pharmaceuticals (Takeda) Latest Developments
Table 75. Genvio Pharma Limited Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 76. Genvio Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 77. Genvio Pharma Limited Main Business
Table 78. Genvio Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 79. Genvio Pharma Limited Latest Developments
Table 80. Beacon Pharma Limited Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 81. Beacon Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 82. Beacon Pharma Limited Main Business
Table 83. Beacon Pharma Limited Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 84. Beacon Pharma Limited Latest Developments
Table 85. Drug International Limted Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 86. Drug International Limted Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 87. Drug International Limted Main Business
Table 88. Drug International Limted Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 89. Drug International Limted Latest Developments
Table 90. Incepta Pharmaceuticals Details, Company Type, Targeted Drug ALK Inhibitors for NSCLC Area Served and Its Competitors
Table 91. Incepta Pharmaceuticals Targeted Drug ALK Inhibitors for NSCLC Product Offered
Table 92. Incepta Pharmaceuticals Main Business
Table 93. Incepta Pharmaceuticals Targeted Drug ALK Inhibitors for NSCLC Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 94. Incepta Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Targeted Drug ALK Inhibitors for NSCLC Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Targeted Drug ALK Inhibitors for NSCLC Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Targeted Drug ALK Inhibitors for NSCLC Sales Market Share by Country/Region (2022)
Figure 8. Targeted Drug ALK Inhibitors for NSCLC Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type in 2022
Figure 10. Targeted Drug ALK Inhibitors for NSCLC in Squamous Cell Carcinoma of NSCLC
Figure 11. Global Targeted Drug ALK Inhibitors for NSCLC Market: Squamous Cell Carcinoma of NSCLC (2018-2023) & ($ Millions)
Figure 12. Targeted Drug ALK Inhibitors for NSCLC in Adenocarcinoma of NSCLC
Figure 13. Global Targeted Drug ALK Inhibitors for NSCLC Market: Adenocarcinoma of NSCLC (2018-2023) & ($ Millions)
Figure 14. Targeted Drug ALK Inhibitors for NSCLC in Large Cell Carcinoma of NSCLC
Figure 15. Global Targeted Drug ALK Inhibitors for NSCLC Market: Large Cell Carcinoma of NSCLC (2018-2023) & ($ Millions)
Figure 16. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application in 2022
Figure 17. Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Player in 2022
Figure 18. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size 2018-2023 ($ Millions)
Figure 20. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size 2018-2023 ($ Millions)
Figure 21. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size 2018-2023 ($ Millions)
Figure 23. Americas Targeted Drug ALK Inhibitors for NSCLC Value Market Share by Country in 2022
Figure 24. United States Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Region in 2022
Figure 29. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type in 2022
Figure 30. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application in 2022
Figure 31. China Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Country in 2022
Figure 38. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
Figure 39. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
Figure 40. Germany Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 54. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 55. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 57. United States Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 58. Canada Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 61. China Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 62. Japan Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 63. Korea Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 65. India Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 66. Australia Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 67. Germany Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 68. France Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 69. UK Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 70. Italy Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 71. Russia Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 72. Spain Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 75. Israel Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 78. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Targeted Drug ALK Inhibitors for NSCLC Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Targeted Drug ALK Inhibitors for NSCLC Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Targeted Drug ALK Inhibitors for NSCLC Sales Market Share by Country/Region (2022)
Figure 8. Targeted Drug ALK Inhibitors for NSCLC Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type in 2022
Figure 10. Targeted Drug ALK Inhibitors for NSCLC in Squamous Cell Carcinoma of NSCLC
Figure 11. Global Targeted Drug ALK Inhibitors for NSCLC Market: Squamous Cell Carcinoma of NSCLC (2018-2023) & ($ Millions)
Figure 12. Targeted Drug ALK Inhibitors for NSCLC in Adenocarcinoma of NSCLC
Figure 13. Global Targeted Drug ALK Inhibitors for NSCLC Market: Adenocarcinoma of NSCLC (2018-2023) & ($ Millions)
Figure 14. Targeted Drug ALK Inhibitors for NSCLC in Large Cell Carcinoma of NSCLC
Figure 15. Global Targeted Drug ALK Inhibitors for NSCLC Market: Large Cell Carcinoma of NSCLC (2018-2023) & ($ Millions)
Figure 16. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application in 2022
Figure 17. Global Targeted Drug ALK Inhibitors for NSCLC Revenue Market Share by Player in 2022
Figure 18. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size 2018-2023 ($ Millions)
Figure 20. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size 2018-2023 ($ Millions)
Figure 21. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size 2018-2023 ($ Millions)
Figure 23. Americas Targeted Drug ALK Inhibitors for NSCLC Value Market Share by Country in 2022
Figure 24. United States Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Region in 2022
Figure 29. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type in 2022
Figure 30. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application in 2022
Figure 31. China Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Country in 2022
Figure 38. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
Figure 39. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
Figure 40. Germany Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Targeted Drug ALK Inhibitors for NSCLC Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 54. APAC Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 55. Europe Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 57. United States Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 58. Canada Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 61. China Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 62. Japan Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 63. Korea Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 65. India Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 66. Australia Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 67. Germany Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 68. France Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 69. UK Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 70. Italy Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 71. Russia Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 72. Spain Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 75. Israel Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Targeted Drug ALK Inhibitors for NSCLC Market Size 2024-2029 ($ Millions)
Figure 78. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Targeted Drug ALK Inhibitors for NSCLC Market Size Market Share Forecast by Application (2024-2029)
